Pro Medicus Limited (ASX: PME)

Australia flag Australia · Delayed Price · Currency is AUD
214.62
0.00 (0.00%)
Nov 21, 2024, 4:10 PM AEST
143.83%
Market Cap 22.43B
Revenue (ttm) 161.50M
Net Income (ttm) 82.79M
Shares Out 104.50M
EPS (ttm) 0.79
PE Ratio 271.33
Forward PE 206.25
Dividend 0.44 (0.21%)
Ex-Dividend Date Sep 4, 2024
Volume 152,704
Open 217.20
Previous Close 214.62
Day's Range 210.89 - 222.04
52-Week Range 85.60 - 222.04
Beta 0.56
Analysts n/a
Price Target n/a
Earnings Date Nov 15, 2024

About Pro Medicus

Pro Medicus Limited, a healthcare informatics company, engages in the development and supply of healthcare imaging software, and radiology information (RIS) system software and services to hospitals, imaging centers, and health care groups in Australia, North America, and Europe. The company offers Visage RIS Visage 7 Enterprise Imaging Platform, a healthcare imaging software that provides radiologists, physicians, and clinicians with access and visualization capability for viewing 2-D, 3-D, and 4-D medical images; and picture archive and commu... [Read more]

Sector Healthcare
Founded 1983
Employees 69
Stock Exchange Australian Securities Exchange
Ticker Symbol PME
Full Company Profile

Financial Performance

In 2024, Pro Medicus's revenue was 161.50 million, an increase of 29.30% compared to the previous year's 124.90 million. Earnings were 82.79 million, an increase of 36.52%.

Financial Statements

News

Earnings-season surprises shake up ASX short sellers

Fortescue, Woodside Energy and Pro Medicus have topped the list of companies being bet against as hedge funds rework their strategies after reporting season.

2 months ago - The Australian Financial Review

Why tech bolters are lighting up reporting season

WiseTech, Pro Medicus, Life 360 and REA Group have turned heads this season as tech proves the sweet spot for growth investors again.

3 months ago - The Australian Financial Review

Pro Medicus share surge defies growth warning

Shares in market darling Pro Medicus jumped on the company’s latest bumper profit, but its CEO says that level of growth will be hard to maintain.

3 months ago - The Australian Financial Review

The five best-performing ASX 200 stocks this financial year

Healthcare software developer Pro Medicus narrowly bested family monitoring app Life360 to be the top-performing stock, with a 118.7 per cent return in 12 months.

5 months ago - The Australian Financial Review

The ASX business so good ‘you can’t put a sell on it’

Analysts say Pro Medicus is one of the world’s most expensive stocks, but also one of the best.

6 months ago - The Australian Financial Review

Why Paradice is backing Seven Group’s bid for Boral

Mid cap investor Jovana Gagic says Kerry Stokes’ conglomerate has a good track record in buying controlling stakes, and reveals why she’s bullish on Orica and Pro Medicus.

8 months ago - The Australian Financial Review

ASX PME:

A $2.8 million share buyback helped restore $1.2 billion of value to Pro Medicus, and bulls think the stock – which is already trading at a sky-high multiple – has further to run.

9 months ago - The Australian Financial Review

Pro Medicus reports 1H results

9 months ago - Seeking Alpha

Pro Medicus Limited (PMCUF) Q4 2023 Earnings Call Transcript

Pro Medicus Limited (PMCUF) Q4 2023 Earnings Call Transcript

10 months ago - Seeking Alpha

The Aussies hoping to make a fortune from Apple’s Vision Pro

The $11 billion ASX software giant Pro Medicus and a Melbourne start-up are among the businesses hoping to cash in on Apple’s new $5000 headset.

10 months ago - The Australian Financial Review

Pro Medicus founders in $176m selldown; Unified Capital nabs trade

Fund managers sources said Anthony Hall and Sam Hupert had stockbroker Unified Capital Partners seeking buyers for 2 million shares at $88 apiece.

1 year ago - The Australian Financial Review

Pro Medicus Limited (PMCUF) Q2 2023 Earnings Call Transcript

Pro Medicus Limited (OTCPK:PMCUF) Q2 2023 Earnings Conference Call February 14, 2023 7:00 PM ET Company Participants Sam Hupert - Chief Executive Officer Clayton Hatch - Chief Financial Officer Confer...

1 year ago - Seeking Alpha

Pro Medicus Limited (PMCUF) CEO Sam Hupert on Q4 2022 Results - Earnings Call Transcript

Pro Medicus Limited (OTCPK:PMCUF) Q4 2022 Earnings Conference Call August 17, 2022 9:00 PM ET Company Participants Sam Hupert - Chief Executive Officer and Managing Director Clayton Hatch - Chief Fina...

2 years ago - Seeking Alpha

Pro Medicus Limited (PMCUF) CEO Sam Hupert On Q2 2022 Results - Earnings Call Transcript

ro Medicus Limited (OTCPK:PMCUF) Q2 2022 Earnings Conference Call February 15, 2022 7:00 PM ET Company Participants Sam Hupert - Chief Executive Officer and Managing Director Clayton Hatch - Chief Fin...

2 years ago - Seeking Alpha

Pro Medicus Limited (PMCUF) CEO Sam Hupert on Half Year 2022 Results - Earnings Call Transcript

Pro Medicus Limited (PMCUF) CEO Sam Hupert on Half Year 2022 Results - Earnings Call Transcript

3 years ago - Seeking Alpha

Pro Medicus' (PMCUF) CEO Sam Hupert on Q4 2021 Results - Earnings Call Transcript

Pro Medicus' (PMCUF) CEO Sam Hupert on Q4 2021 Results - Earnings Call Transcript

3 years ago - Seeking Alpha

Pro Medicus Limited (PMCUF) CEO Sam Hupert on Q2 2021 Results - Earnings Call Transcript

Pro Medicus Limited (PMCUF) CEO Sam Hupert on Q2 2021 Results - Earnings Call Transcript

4 years ago - Seeking Alpha

Pro Medicus Limited (PMCUF) CEO Sam Hupert on Q4 2020 Results - Earnings Call Transcript

Pro Medicus Limited (PMCUF) CEO Sam Hupert on Q4 2020 Results - Earnings Call Transcript

4 years ago - Seeking Alpha

Pro Medicus: Healthcare IT Developer With Impressive Growth Story

Pro Medicus: Healthcare IT Developer With Impressive Growth Story

4 years ago - Seeking Alpha

Pro Medicus: An Emerging Star In Digital Healthcare

Pro Medicus has been an exceptionally strong performer for my high growth, Project $1M portfolio, returning more than 250% over the last 3 years .

5 years ago - Seeking Alpha